InnoGrant Advisors is an innovation and funding advisory firm helping biotech companies and cross-industry technology providers launch and scale collaborative projects with international partners. We work at the interface of science, strategy, and finance—supporting teams to (1) sharpen the value proposition and clinical/market relevance, (2) design robust workplans and consortia, and (3) secure public and blended financing (Eureka network instruments, Horizon Europe, Innosuisse and complementary regional/national programs). We are particularly interested in collaborations connecting diagnostics, lab automation, digital health, therapeutics/medtech combination products, and industrial biotech with enabling capabilities such as digitalisation, translational research, chemistry, manufacturing scale-up, and CMC/QC. If you are building an international project and need the right partners, a compelling funding narrative, or a route to measurable market pull, we would welcome a conversation at GIS 2026. Matchmaking add-on (highly effective on event platforms) What we offer: Partner sourcing and consortium design for international collaborative projects Investability and funding workshops Funding readiness Funding strategy and proposal architecture (Eureka/Horizon/Innosuisse alignment) Commercialization planning: market pull, pricing/reimbursement logic, stakeholder mapping GTM Strategy Scale-up readiness Board roles Fractional CXO / Entrepreneur in Residence Innovation Mentoring What we are looking for: Biotech SMEs, scale-ups, and technology providers seeking international project partners and funding (public or private) Large industrial partners ready to scale innovation Diagnostics/lab automation/digital health innovators with clear clinical or operational use cases Manufacturing/CMC/QC, CDMO, data/AI, and digitalisation partners enabling translation and scale Academic/RTO groups ready to engage in industry-driven, impact-oriented consortia
I am the Founder &CEO of InnoGrant Advisors boutique innovation and funding consultancy, where we as management consultants focus on scaling innovation through combining public and private funding for companies in European, UK and DACH national funding, and private investments. We offer full funding support for both companies and investors.
Having led corporate open innovation globally, and worked as corporate venture capitalist in the chemicals and life sciences, I am deeply involved in deal flows and investment opportunities in Switzerland, Europe and beyond, building strategic partnerships between industry, academia, RTOs and startups.
As Innosuisse Innovation Mentor I guide Swiss SME's in their funding journey through Swiss and European funding, including EUREKA.
As EIC BAS Ecosystem Partner and Entrepreneur in Residence, I helped build PureSurf venture, developing extremely high performing, sustainable, and biobased surfactants.